Psychosis induced by low-dose bupropion: Sensitization of dopaminergic system by past cocaine abuse?

Journal of Psychiatric Practice

Volumn 13, Issue 5, 2007, Pages 336-338

  Hahn, Margaret ^c   Hajek, Tomas ^c,d   Alda, Martin ^c,e   Gorman, Jack M ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Univ S Carolina Sch Med Vice P

^c DALHOUSIE UNIVERSITY   (Canada)

^d CHARLES UNIVERSITY   (Czech Republic)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CLONAZEPAM; COCAINE; METHADONE; OPIATE;

ADULT; ANXIETY DISORDER; ARTICLE; BRIEF PSYCHOTIC DISORDER; CASE REPORT; COCAINE DEPENDENCE; DOPAMINE RELEASE; DRUG ABUSE; HIP INJURY; HUMAN; MAJOR DEPRESSION; MALE; PARANOIA; PSYCHOSIS;

ADULT; BUPROPION; COCAINE; COCAINE-RELATED DISORDERS; DELAYED-ACTION PREPARATIONS; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; PSYCHOSES, SUBSTANCE-INDUCED;

EID: 34748901829     PISSN: 15274160     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pra.0000290673.32978.e8     Document Type: Article

References (18)

1. Settle EC, Jr. Bupropion sustained release: Side effect profile. J Clin Psychiatry 1998;59(suppl 4):32-6.
2. Boileau I, Dagher A, Leyton M, et al. Modeling sensitization to stimulants in humans: An [11C]raclopride/positron emission tomography study in healthy men. Arch Gen Psychiatry 2006;63:1386-95.
3. Learned-Coughlin SM, Bergstrom M, Savitcheva I, et al. In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography. Biol Psychiatry 2003;54:800-5.
4. Volkow ND, Wang GJ, Fischman MW, et al. Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature 1997;386:827-30.
5. Neumann M, Livak V, Paul HW, et al. Acute psychosis after administration of bupropion hydrochloride (Zyban). Pharmacopsychiatry 2002;35:247-8.
6. Golden RN, James SP, Sherer MA, et al. Psychoses associated with bupropion treatment. Am J Psychiatry 1985;142:1459-62.
7. Becker RE, Dufresne RL. Perceptual changes with bupropion, a novel antidepressant. Am J Psychiatry 1982;139:1200-1.
8. Ames D, Wirshing WC, Szuba MP. Organic mental disorders associated with bupropion in three patients. J Clin Psychiatry 1992;53:53-5.
9. Howard WT, Warnock JK. Bupropion-induced psychosis. Am J Psychiatry 1999;156:2017-8.
10. Goetz CG, Tanner CM, Klawans HL. Bupropion in Parkinson's disease. Neurology 1984;34:1092-4.
11. Fruensgaard K. Withdrawal psychosis: A study of 30 consecutive cases. Acta Psychiatr Scand 1976; 53:105-18.
12. Panikkar GP. Cocaine addiction: Neurobiology and related current research in pharmacotherapy. Subst Abus 1999;20:149-66.
13. Nomikos GG, Damsma G,Wenkstern D, et al. Effects of chronic bupropion on interstitial concentrations of dopamine in rat nucleus accumbens and striatum. Neuropsychopharmacology 1992;7:7-14.
14. Satel SL, Southwick SM, Gawin FH. Clinical features of cocaine-induced paranoia. Am J Psychiatry 1991;148:495-8.
15. Brady KT, Lydiard RB, Malcolm R, et al. Cocaine-induced psychosis. J Clin Psychiatry 1991;52:509-12.
16. Bartlett E, Hallin A, Chapman B, et al. Selective sensitization to the psychosis-inducing effects of cocaine: A possible marker for addiction relapse vulnerability? Neuropsychopharmacology 1997;16:77-82.
17. Dwoskin LP, Rauhut AS, King-Pospisil KA, et al. Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent. CNS Drug Rev 2006;12:178-207.
18. Nestler E: Historical review: Molecular and cellular mechanisms of opiate and cocaine addiction. Trends Pharmacol Sci 2004;25:210-8.